Incyte reports better-than-expected first-quarter 2025 results, beating both earnings and revenue estimates, driven by strong Jakafi and Opzelura sales.

Incyte Corp raised its annual sales forecast for its blood cancer treatment Jakafi on Tuesday, after robust sales of the drug helped it beat Wall Street estimates for quarterly results.

Panelists discuss how thrombotic risk assessment—anchored in age, thrombotic history, and additional factors like leukocytosis and JAK2 allele burden—guides personalized therapy in polycythemia vera ...

Cardiovascular risk factors increase the risk of arterial and venous thrombosis in patients with myeloproliferative neoplasms ...

INCY is likely to beat Q1 earnings estimates, primarily driven by increased U.S. sales and royalties from Novartis on ex-U.S. sales of its lead drug, Jakafi.

Hany Elmariah, MD, discusses how he sees fedratinib fitting into clincal practice for the treatment of myeloproliferative neoplasms.

A men’s bantamweight contest between one-time title challenger Marlon Vera and the streaking Mario Bautista was also added to the card, as was a men’s flyweight bout between Bruno Silva and ...

The machine learning model enhances transplant risk assessment for myelofibrosis by accurately identifying high-risk patients, outperforming traditional methods. A simplified 10-variable model ...

(AP Photo/Jose Luis Magana, File) Nick Turner, president of the Vera Institute of Justice, poses for a portrait in their office, Thursday, April 17, 2025, in New York. (AP Photo/Pamela Smith) Nick ...

NEW YORK — The nonprofit Vera Institute of Justice says staff from Elon Musk’s Department of Government Efficiency contacted them to assign a team to the organization and told them they ...

Advertisement The Las Vegas-based promotion announced on Tuesday that Marlon Vera vs. Mario Bautista will square off at bantamweight, while Johnny Walker will face Azamat Murzakanov on the ...